Am I a candidate for NAD+?
NAD+ is reviewed for adults with cellular, metabolic, and longevity-axis goals. Baseline is light. There are few absolute contraindications, but pregnancy, active malignancy, and selected conditions warrant individualized provider review.
Full answer
NAD+ therapy supports cellular energy metabolism, sirtuin activity, and longevity-axis pathways. Candidacy is broad in healthy adults pursuing energy, cognitive, and longevity goals. The baseline is lighter than hormone optimization but a metabolic and hepatic baseline is reviewed. Pregnancy, active malignancy, and selected medical conditions warrant individualized provider review. Expectations are framed: NAD+ is a supportive lever, not a primary treatment for any disease. Every initiation is synchronous-video reviewed.
Educational. Not a substitute for individualized provider review.
- NAD+ pathway — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-06-03